Letters to the Editor

Long COVID – Reader Response

Share

In Response to: Keys to understanding long COVID

Dear Dr. Gelinas,

Thank you for your June 2023 editorial on long COVID. I appreciate your interest!

I contracted COVID twice in 2020. Both times I experienced global HA, brain fog, anxiety, bright light/noise intolerance & insomnia.

I had more difficulty performing my job as ED of the Nebraska Future of Nursing: Campaign for Action Coalition. I suffered an iatrogenic side effect after being prescribed Vybrid; I nearly went into what’s called Serotonin Syndrome. All senses became super heightened. I was extremely scared, paranoid, & anxious and had thoughts of suicide. By October 1 had to quit my job because I could no longer concentrate.

In late December 2020 I was handcuffed & admitted to a psych hospital against my will. I felt it was an overreaction; I was giddy but not making risky choices. I was diagnosed with bipolar disorder at the age of 64, an unusual diagnosis for someone who had never experienced mania.

Over the next 18 mos. I experienced gingivitis, finger & toe neuropathies, diarrhea, weight loss, & continued anxiety and insomnia. I was hospitalized again in May 2022 this time for anxiety & difficulty speaking. I spent 2 weeks at one hospital & was discharged walking as if I had Parkinson’s. I got readmitted to a different hospital & received the care I needed.

I am now 13 mos. post hospitalization & fully enjoying & participating in life. I truly believe in nurse advocacy for individuals facing complex medical care & hospitalization. I would otherwise probably still be feeling like a zombie, shuffling my feet, & thinking life as I had known it was no longer possible.

Victoria Vinton RN, MSN
Health Advocate
Chair Legislative Committee for NE Women’s Health Initiative Advisory Council

Are you interested in sharing your input?
Please consider sending an electronic Letter to the Editor to share your opinion on American Nurse Journal content.

What are the guidelines for letter submissions?
Letters should be fewer than 275 words and take as their starting point an article published in American Nurse Journal in the past 2 months. Letters should be exclusive to American Nurse Journal and not submitted to or published in any other media. They must include the writer’s full name. Anonymous letters and letters written under pseudonyms will not be considered. Writers should disclose any personal or financial interest in the subject matter of their letters. Letters should not contain attachments.

Letters are screened prior to approval for posting; not all will be posted. We do not respond to requests for medical or legal advice. No material is intended to be a substitute for professional medical and legal advice.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.


cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

Which of the following patients is at the highest risk for developing autonomic dysreflexia (AD)?

Recent Posts